Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Boni

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Future Oncology (London, England)|July 31, 2014
Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancerElisa Borsò, Giuseppe Boni, Luca Galli, et al.
Endocrine|August 9, 2013
The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosisDaniele Barbaro, Roberto Mario Incensati, Gabriele Materazzi, et al.
Cardiovascular and Interventional Radiology|September 14, 2022
Role of Transhepatic Arterial Radioembolization in Metastatic Colorectal CancerIrene Bargellini, Elena Bozzi, Giulia Lorenzoni, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablationDaniele Barbaro, Giuseppe Boni, Giuseppe Meucci, et al.
The Journal of Clinical Endocrinology and Metabolism|April 26, 2021
[18F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient SurvivalLaura Valerio, Federica Guidoccio, Carlotta Giani, et al.
European Radiology|March 12, 2004
CT-guided radiofrequency ablation of osteoid osteoma: long-term resultsRoberto Cioni, Nicola Armillotta, Irene Bargellini, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 1, 2003
Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancerFranca M A Melfi, Antonio Chella, G Franco Menconi, et al.
Clinical Endocrinology|January 19, 2019
Comparison between radioiodine therapy and single-session radiofrequency ablation of autonomously functioning thyroid nodules: A retrospective studyRosa Cervelli, Salvatore Mazzeo, Giuseppe Boni, et al.
Clinical Nuclear Medicine|January 29, 2019
Effect of Sentinel Node Biopsy in Clinically N0, BRAF V600E-Mutated, Small Papillary Thyroid Carcinoma: A Pilot StudyMarco Puccini, Gianpiero Manca, Carlo Maria Neri, et al.
The Journal of Clinical Endocrinology and Metabolism|January 25, 2007
Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiterAlessandro Antonelli, Mario Rotondi, Poupak Fallahi, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Future Oncology (London, England)|July 31, 2014
Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancerElisa Borsò, Giuseppe Boni, Luca Galli, et al.
Endocrine|August 9, 2013
The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosisDaniele Barbaro, Roberto Mario Incensati, Gabriele Materazzi, et al.
Cardiovascular and Interventional Radiology|September 14, 2022
Role of Transhepatic Arterial Radioembolization in Metastatic Colorectal CancerIrene Bargellini, Elena Bozzi, Giulia Lorenzoni, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablationDaniele Barbaro, Giuseppe Boni, Giuseppe Meucci, et al.
The Journal of Clinical Endocrinology and Metabolism|April 26, 2021
[18F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient SurvivalLaura Valerio, Federica Guidoccio, Carlotta Giani, et al.
European Radiology|March 12, 2004
CT-guided radiofrequency ablation of osteoid osteoma: long-term resultsRoberto Cioni, Nicola Armillotta, Irene Bargellini, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 1, 2003
Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancerFranca M A Melfi, Antonio Chella, G Franco Menconi, et al.
Clinical Endocrinology|January 19, 2019
Comparison between radioiodine therapy and single-session radiofrequency ablation of autonomously functioning thyroid nodules: A retrospective studyRosa Cervelli, Salvatore Mazzeo, Giuseppe Boni, et al.
Clinical Nuclear Medicine|January 29, 2019
Effect of Sentinel Node Biopsy in Clinically N0, BRAF V600E-Mutated, Small Papillary Thyroid Carcinoma: A Pilot StudyMarco Puccini, Gianpiero Manca, Carlo Maria Neri, et al.
The Journal of Clinical Endocrinology and Metabolism|January 25, 2007
Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiterAlessandro Antonelli, Mario Rotondi, Poupak Fallahi, et al.
Pageof 6